Late onset veno-occlusive disease following high-dose chemotherapy and stem cell transplantation

Bone Marrow Transplantation

Volumn 24, Issue 8, 1999, Pages 891-895

  Toh, H C ^a   McAfee, S L ^a   Sackstein, R ^a   Cox, B F ^a   Colby, C ^a   Spitzer, T R ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

High dose chemotherapy; Late onset VOD; Peripheral blood stem cell transplantation; Ursodeoxycholic acid; VOD risk factors

Indexed keywords

ALKANESULFONIC ACID DERIVATIVE; BILIRUBIN; BUSULFAN; URSODEOXYCHOLIC ACID;

ADULT; AGED; ARTICLE; CASE REPORT; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROPHYLAXIS; RETROSPECTIVE STUDY; STEM CELL TRANSPLANTATION; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; VEIN OCCLUSION;

EID: 0032734090     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701994     Document Type: Article

References (21)

1. Richardson PG, Elias AD, Krishnan A et al. Treatment of severe veno-occlusive disease with defibrotide: compassionate use results in response without significant toxicity in a high-risk population. Blood 1998; 92: 737-744.
2. Rozman C, Carreras E, Qian C et al. Risk factors for hepatic veno-occlusive disease following HLA-identical sibling bone marrow transplants for leukemia. Bone Marrow Transplant 1996; 17: 75-80.
3. McDonald GB, Hinds MS, Fisher LD et al. Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients. Ann Intern Med 1993; 118: 255-267.
4. Carreras E, Granena A, Navasa M et al. On the reliability of clinical criteria for the diagnosis of hepatic veno-occlusive disease. Ann Hematol 1993; 66: 77-80.
5. Jones RJ, Lee KSK, Beschorner WE et al. Venoocclusive disease of the liver following bone marrow transplantation. Transplantation 1987; 44: 778-783.
6. Baglin TP. Veno-occlusive disease of the liver complicating bone marrow transplantation. Bone Marrow Transplant 1994; 13: 1-4.
7. Bearman SI, Anderson GL, Mori M et al. Venoocclusive disease of the liver: development of a model predicting fatal outcome after marrow transplantation. J Clin Oncol 1993; 11: 1729-1736.
8. Rollins BJ. Hepatic veno-occlusive disease. Am J Med 1986; 81: 297-306.
9. Reed GB, Cox AJ. The human liver after radiation injury: a form of veno-occlusive disease. Am J Pathol 1966; 48: 597-612.
10. McLean EK. The toxic actions of pyrrolizidine (senecio) alkaloids. Pharmacological Review, vol 22. Williams & Wilkins: Baltimore, 1970.
11. Bras G, Jellife DB, Stuart KL. Veno-occlusive disease of the liver with non-portal type of cirrhosis, occurring in Jamaica. Arch Pathol 1954; 57: 285-300.
12. Carreras E, Bertz H, Arcese W et al. Incidence and outcome of hepatic veno-occlusive disease after blood or marrow transplantation: a prospective cohort study of the European Group for Blood and Marrow Transplantation. Blood 1998; 92: 3599-3604.
13. Bearman SI. The syndrome of hepatic veno-occlusive disease after marrow transplantation. Blood 1995; 85: 3005-3020.
14. Hartman AR, Williams SF, Dillon JJ. Survival, disease-free survival and adverse effects of conditioning for allogeneic bone marrow transplantation with busulfan/cyclophosphamide vs total body irradiation: a meta-analysis. Bone Marrow Transplant 1998; 22: 439-443.
15. Shulman HM, Hinterberger W. Hepatic veno-occlusive disease - liver toxicity syndrome after bone marrow transplantation. Bone Marrow Transplant 1992; 10: 197-214.
16. Styler MJ, Crilley P, Biggs J et al. Hepatic dysfunction following busulfan and cyclophosphamide myeloablation: a retrospective, multicenter analysis. Bone Marrow Transplant 1996; 18: 171-176.
17. Essell JH, Schroeder MT, Harman GS et al. Ursodiol prophylaxis against hepatic complications of allogeneic bone marrow transplantation. Ann Intern Med 1998; 128: 975-981.
18. Calmus Y, Gane P, Rouger P, Poupon R. Hepatic expression of class I and class II major histocompatibility complex molecules in primary biliary cirrhosis: effect of ursodeoxycholic acid. Hepatology 1990; 78: 321-325.
19. McDonald GB, Sharma P, Matthews DE et al. Venoocclusive disease of the liver after bone marrow transplantation: diagnosis, incidence, and predisposing factors. Hepatology 1984; 4: 116-122.
20. Moreau P, Milpied N, Voillat L et al. Peripheral blood stem cell transplantation as front-line therapy in patients aged 61 to 65 years: a pilot study. Bone Marrow Transplant 1998; 21: 1193-1196.
21. Weaver CH, West W, Schwartzberg L et al. The rationale for performing autologous peripheral blood stem cell transplants in community cancer centers. Oncologist 1998; 3: 346-353.